These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 12038780)
1. Patients with essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis. Harrison CN; Donohoe S; Carr P; Dave M; Mackie I; Machin SJ Thromb Haemost; 2002 May; 87(5):802-7. PubMed ID: 12038780 [TBL] [Abstract][Full Text] [Related]
2. Frequency of vascular and pregnancy morbidity in patients with low vs. moderate-to-high titers of antiphospholipid antibodies. Ofer-Shiber S; Molad Y Blood Coagul Fibrinolysis; 2015 Apr; 26(3):261-6. PubMed ID: 25526601 [TBL] [Abstract][Full Text] [Related]
3. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies. Viveros ME; Cabiedes J; Reyes E; Cabral AR Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641 [TBL] [Abstract][Full Text] [Related]
4. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis. Ishikura K; Wada H; Kamikura Y; Hattori K; Fukuzawa T; Yamada N; Nakamura M; Nobori T; Nakano T Am J Hematol; 2004 Aug; 76(4):338-42. PubMed ID: 15282665 [TBL] [Abstract][Full Text] [Related]
5. Anti-beta 2-glycoprotein I antibodies of IgM class are linked to thrombotic disorders in young women without autoimmune disease. Salobir B; Sabovic M; Hojnik M; Cucnik S; Kveder T Immunobiology; 2007; 212(3):193-9. PubMed ID: 17412286 [TBL] [Abstract][Full Text] [Related]
6. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome. Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941 [TBL] [Abstract][Full Text] [Related]
12. Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment. Asherson RA; Cervera R; Merrill JT; Erkan D Semin Thromb Hemost; 2008 Apr; 34(3):256-66. PubMed ID: 18720305 [TBL] [Abstract][Full Text] [Related]
13. Identification of thrombin antibodies in patients with antiphospholipid syndrome. Miesbach W; Matthias T; Scharrer I Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540 [TBL] [Abstract][Full Text] [Related]
14. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies. Jy W; Tiede M; Bidot CJ; Horstman LL; Jimenez JJ; Chirinos J; Ahn YS Thromb Res; 2007; 121(3):319-25. PubMed ID: 17582471 [TBL] [Abstract][Full Text] [Related]
15. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients. Tarr T; Lakos G; Bhattoa HP; Shoenfeld Y; Szegedi G; Kiss E Lupus; 2007; 16(1):39-45. PubMed ID: 17283584 [TBL] [Abstract][Full Text] [Related]
16. The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus. Nojima J; Iwatani Y; Suehisa E; Kuratsune H; Kanakura Y Haematologica; 2006 May; 91(5):699-702. PubMed ID: 16627257 [TBL] [Abstract][Full Text] [Related]
17. Analysis of prothrombotic effects of two human monoclonal IgG antiphospholipid antibodies of apparently similar specificity. Lackner KJ; von Landenberg C; Barlage S; Schmitz G Thromb Haemost; 2000 Apr; 83(4):583-8. PubMed ID: 10780321 [TBL] [Abstract][Full Text] [Related]
18. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus. Danowski A; de Azevedo MN; de Souza Papi JA; Petri M J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935 [TBL] [Abstract][Full Text] [Related]